echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The patients with COVID-19 improved after the treatment of tozhuzumab.

    The patients with COVID-19 improved after the treatment of tozhuzumab.

    • Last Update: 2020-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to an observational study by Cedars-Sinai Medical Center, the majority of patients hospitalized with COVID-19 (coronavirus) pneumonia improved after receiving FDA-approved medication for rheumatoid arthritis.
    had lower risk of inflammation, oxygen demand, blood pressure support, and death in patients with toluzumab compared to published reports of illness and death associated with COVID-19 severe illness. "Based on our preliminary results, I hope these drugs can help improve the condition in patients with COVID-19 pneumonia," Jordan said.

    ", but we couldn't know the results until a randomized controlled clinical trial was completed.
    " this article from Bio Valley, for more information please download Bio Valley APP (
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.